• Staffordshire University Featured PhD Programmes
  • FindA University Ltd Featured PhD Programmes
  • University of Pennsylvania Featured PhD Programmes
  • University of Tasmania Featured PhD Programmes
  • Aberdeen University Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
University of York Featured PhD Programmes
University of Bristol Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Reading Featured PhD Programmes

Towards new antibacterial drugs to treat infections caused by multidrug-resistant bacteria: identification and characterization of novel natural product antibiotics

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

The World Health Organization (WHO) has declared antimicrobial drug resistance one of the greatest problems currently facing human health, and the situation is especially grave in the case of infections caused by bacterial pathogens. Compounding the issue, in the last 40 years only two structurally-novel antibacterial classes have been successfully developed for treating life-threatening bacterial infections.

The majority of our existing antibacterial armamentarium are microbial products; despite this, most antibacterial drug discovery programmes have abandoned the search for novel natural product antibiotics, favoring instead rational synthetic chemistry approaches which have yet to bear fruit.

The proposed studentship intends to utilize several innovative approaches to find and characterize novel antibiotic classes produced by micro-organisms, with a view to ultimately developing drugs active against multi-drug resistant bacterial pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa.







Funding Notes

Please visit View Website

References

Hawkey, P. M. (2008). The growing burden of antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 62 (Supplement 1), i1-i9. doi: 10.1093/jac/dkn241.
Talbot, G. H., Bradley, J., Edwards Jr., J. E., Gilbert, D., Scheld, M., Bartlett, J. G., et al. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis., 42 (5), 657-68.

How good is research at University of Leeds in Biological Sciences?

FTE Category A staff submitted: 60.90

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.
Email Sent

Share this page:

Cookie Policy    X